Tech Center 1600 • Art Units: 1615 1654
This examiner grants 65% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19335896 | MODIFIED RELEASE GAMMA- HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED PHARMACOKINETICS | Non-Final OA | Flamel Ireland Limited |
| 18613904 | COMPOSITIONS COMPRISING BIOACTIVE GLASS AND AMINO ACID | Non-Final OA | CORNING INCORPORATED |
| 18546602 | AMORPHOUS FORM AND COMPOSITION CONTAINING SAID AMORPHOUS FORM | Final Rejection | OTSUKA PHARMACEUTICAL CO., LTD. |
| 18690379 | AQUEOUS COMPOSITION COMPRISING A FATTY DIALKYL ETHER, AN ANIONIC SURFACTANT WITH AT LEAST ONE CATIONIC COUNTERION AND A NONIONIC SURFACTANT | Non-Final OA | L'OREAL |
| 18640463 | METHOD OF PREPARING POUCH FILLING MATERIAL USING BINDER | Non-Final OA | KT&G Corporation |
| 17801949 | NON-CORROSIVE FORMULATION COMPOSITION FOR NITROGEN INHIBITORS | Final Rejection | Verdesian Life Sciences U.S., LLC |
| 18093654 | ORAL GEL COMPOSITIONS | Non-Final OA | Colgate-Palmolive Company |
| 18291029 | LIGHT-COLORED CATECHOL LIGNOSULFONATE SUNSCREEN MICROCAPSULE, AND PREPARATION THEREFOR AND USE THEREOF | Non-Final OA | South China University of Technology |
| 18016189 | COMPOSITIONS AND METHODS OF TREATING UPS-ASSOCIATED DISEASES | Final Rejection | Board of Supervisors of Louisiana State University and Agricultural and Mechanical College |
| 18697581 | A Nano Emulsified Phyto-Drug For Transdermal Treatment of Diabetes | Non-Final OA | University of South Africa |
| 18023119 | COMPOSITION FOR AMELIORATING UNPLEASANT STATE CAUSED BY MENSTRUATION | Non-Final OA | ROHTO PHARMACEUTICAL CO., LTD. |
| 18614077 | LIPID NANOPARTICLES ENCAPSULATION OF LARGE RNA | Non-Final OA | Arcturus Therapeutics, Inc. |
| 18585371 | SUNSCREEN PREPARATION | Non-Final OA | BEIERSDORF AG |
| 18681256 | ANTIMICROBIAL COMPOSITIONS | Non-Final OA | Firmenich SA |
| 18568202 | DISSOLUTION RESISTANT TISSUE ADHERENT DRESSING APPLICATION AND ITS DELIVERY | Non-Final OA | TRICOL BIOMEDICAL, INC. |
| 18573229 | PHARMACEUTICAL COMPOSITIONS OF AN EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITOR | Non-Final OA | Blueprint Mdeicines Coroporation |
| 18568415 | PHARMACEUTICAL COMPOSITION, PREPARATION, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Non-Final OA | WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD. |
| 18525295 | COMPOSITIONS COMPRISING POROUS MICROPARTICLES AND METHODS OF USING THE SAME | Non-Final OA | WEST CHESTER UNIVERSITY |
| 18564552 | CO-AMORPHOUS FORMS FOR USE IN CANCER THERAPY | Non-Final OA | Zerion Pharma APS |
| 18562212 | ORODISPERSIBLE EFFERVESCENT TABLET COMPRISING BUDESONIDE FOR USE IN THE TREATMENT OF EOSINOPHILIC ESOPHAGITIS | Non-Final OA | Dr. Falk Pharma GmbH |
| 18283585 | PHARMACEUTICAL COMPOSITION FOR IMPROVING CARDIAC FUNCTION | Final Rejection | CUORIPS INC. |
| 18451355 | Food Contact Disinfecting/Sanitizing Formulation And Wipe | Final Rejection | ARXADA, LLC |
| 18467324 | Compositions of Iboga Alkaloids and Methods of Treatment | Non-Final OA | Soneira Inc., P.B.C. |
| 18447880 | STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME | Non-Final OA | Amarin Pharmaceuticals Ireland Limited |
| 18276396 | INHALABLE IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF | Non-Final OA | Aerovate Therapeutics, Inc. |
| 18272796 | AMLODIPINE DRY SUSPENSION AND PREPARATION METHOD THEREFOR | Non-Final OA | APICHOPE BIO PHARMACEUTICAL CO., LTD. |
| 18261679 | AN AQUEOUS GEL COMPOSITION COMPRISING AN ETHYLCELLULOSE | Non-Final OA | DANISCO NUTRITION AND BIOSCIENCES INDIA PVT. LTD. |
| 18318133 | VETERINARY PHARMACEUTICAL FORMULATIONS | Non-Final OA | INCREVET, INC. |
| 18251611 | OPHTHALMIC COMPOSITION | Non-Final OA | IROMED GROUP S.R.L. |
| 18033699 | COMPOSITION FOR PREVENTING, AMELIORATING OR TREATING SLEEP DISORDER OR INSOMNIA, CONTAINING EXTRACT OF ROASTED CITRUS BYPRODUCT AS ACTIVE INGREDIENT | Final Rejection | NUTRA-IT INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy